KYIV. Dec 19 (Interfax-Ukraine) – The European Bank for Reconstruction and Development (EBRD) will issue a credit of up to $3.8 million to Ukrainian pharmaceutical manufacturer Ecofarm (Ecopharm) to complete the construction of production facilities according to GMP standards in Slavuta and procurement of appropriate equipment, the EBRD press service has said.
The loan will be granted for seven years in the framework of the EBRD direct financing program aimed at providing local small and medium enterprises with easier access to long-term financing, the report says.
The project also foresees investment support in the framework of the EU4Business program, which will help Ecofarm in its implementation.
Ecofarm is a Ukrainian pharmaceutical company, founded in 1998. It specializes in production of plant antiviral drugs.
According to information in the state register, the ultimate beneficial owner of the company through Valora Financial Services (the British Virgin Islands) is citizen of Switzerland Ruslan Novik.
